Ballentine Partners’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,968
Closed -$327K 955
2024
Q4
$327K Buy
2,968
+295
+11% +$33.8K 0.01% 567
2024
Q3
$302K Sell
2,673
-1,010
-27% -$118K 0.01% 585
2024
Q2
$455K Sell
3,683
-725
-16% -$90.7K 0.01% 426
2024
Q1
$568K Buy
4,408
+2,222
+102% +$270K 0.01% 364
2023
Q4
$269K Buy
+2,186
New +$233K 0.01% 535

Other funds holding IOSP

Ballentine Partners's IOSP Position: Q1 2025 in Review

Ballentine Partners sold out of Innospec (IOSP) in Q1 2025, closing a stake of 2,968 shares — an estimated $327K sold.

Ballentine Partners first reported a position in IOSP in Q4 2023 and held it in 5 quarters. The position peaked at $568K in Q1 2024. 272 funds tracked by Wall St. Rank hold IOSP as of Q1 2025.

  • Ballentine Partners reported no remaining Innospec position as of Q1 2025 after selling out during the quarter.
  • Ballentine Partners sold 2,968 Innospec shares in Q1 2025, an estimated $327K.
  • Ballentine Partners first reported a position in Innospec in Q4 2023 and held it in 5 quarters.
  • Ballentine Partners's Innospec position peaked at $568K in Q1 2024.
  • 272 funds tracked by Wall St. Rank held Innospec as of Q1 2025.

Based on Ballentine Partners's 13F filing for Q1 2025, filed 1 May 2025.